It is an extensive review of a complex issue concerning both women and schizophrenia, including the biological, endocrine, epidemiological, reproductive, psychological, and social implications of this disease in women. The female nature significantly influences the onset and manifestation of schizophrenia: the female brain develops faster than the male brain; estrogen has antipsychotic properties; the female brain ages differently from the male brain, resulting in the overwhelming predominance of early-onset schizophrenia in women, possibly due to a relative excess of D2 dopamine receptors.
An international group of multidisciplinary doctors and mental health researchers examine the old and modern literature, assess gender-related perspectives, and evaluate their therapeutic, clinical, and social implications for the most appropriate and effective treatment of schizophrenia in women now and in the future. This book should be read by all clinical and private doctors and researchers dealing with mental health and women's health.